Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Genenta Science S.P.A. ADR (GNTA)

Genenta Science S.P.A. ADR (GNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer Business Wire - Tue Jan 17, 2023

Corium Pharma Solutions, Inc. (“Corium Pharma Solutions” or “CPSI”), a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies,...

PG : 169.11 (+1.32%)
AGRX : 1.4500 (+0.69%)
NMTR : 0.0722 (-42.97%)
GNTA : 4.19 (-2.56%)
AmCham Italy and Genenta Science Announce the Bowling Green Bull Initiative Globe Newswire - Mon Jul 25, 2022

Think tank of Italian companies and entrepreneurs listed or to be listed on US capital markets...

GNTA : 4.19 (-2.56%)
Genenta to Present at Upcoming Scientific Congresses ASGCT, BTM, ASCO and EHA Globe Newswire - Fri May 13, 2022

MILAN, Italy and NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the...

GNTA : 4.19 (-2.56%)
Genenta Appoints Industry Veteran Tim Obara as Head of Business Development Globe Newswire - Mon May 9, 2022

Extensive experience in business development with AstraZeneca and GSK...

GNTA : 4.19 (-2.56%)
Genenta Files Annual Report on Form 20-F for Fiscal Year 2021 Globe Newswire - Wed May 4, 2022

MILAN, Italy and NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the...

GNTA : 4.19 (-2.56%)
Genenta Progresses to Higher Dosing Cohort in Temferon™ Phase 1/2a Clinical Trial in Glioblastoma Multiforme Globe Newswire - Wed May 4, 2022

No dose limiting toxicity observed in previous three dose level cohortsRepresents a 50% higher dose than highest prior levelUpdate of guidance for trial ...

GNTA : 4.19 (-2.56%)
Genenta ASGCT Clinical Data Highlights Temferon™ Biological Effects in Glioblastoma Globe Newswire - Mon May 2, 2022

Initial evidence of potential to modulate tumor microenvironment...

GNTA : 4.19 (-2.56%)
Genenta Announces Nomination of Mark A. Sirgo as Chair Globe Newswire - Wed Apr 27, 2022

35 years industry experience including as CEO and founder of public company Stephen Squinto steps down as Chair for new role MILAN, Italy and NEW YORK,...

GNTA : 4.19 (-2.56%)
Genenta to Host Expert Fireside Chat on Immuno Gene & Cell Therapy for Treatment of Solid Tumors Globe Newswire - Wed Apr 20, 2022

*** David Reardon, Luigi Naldini, Brad Loncar ***...

GNTA : 4.19 (-2.56%)
Genenta Data Presentation at AACR to Describe On-Target Biological Activity of Temferon™ in Unmethylated Glioblastoma Multiforme Globe Newswire - Wed Mar 9, 2022

Data to be presented at the 2022 annual meeting of American Association for Cancer Research...

GNTA : 4.19 (-2.56%)

Barchart Exclusives

Up 128% YTD, Should You Still Invest in Nvidia Stock? Barchart - Sat Jul 27, 10:45AM CDT
For investors looking to capitalize on a leader in the AI revolution, Nvidia remains a compelling opportunity with a promising outlook. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot